Clinical trial

The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem…

NCT00473408 · Haukeland University Hospital, Other · Terminated

Key facts

NCT number NCT00473408
Title The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
Official title The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
Acronym Gliomstudien
Lead sponsor Haukeland University Hospital, Other
Collaborators University of Bergen
Status Terminated
Study type Observational
Conditions Anaplastic Astrocytoma, Glioblastoma Multiforme, Tumor Angiogenesis
Intervention type Device, Procedure
Interventions Functional MRI (DCE-MRI), Blood sample, Tumor sample
Enrollment 1
Start date Mar 1, 2007
Primary completion May 1, 2007
Completion Nov 1, 2011
First posted May 15, 2007
Last update posted Dec 6, 2016
Countries Norway

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies